Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Omalizumab, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Contract T 2026-08-10
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A Abs. 8 Sgb V For Contracts Of Biosimilar Active Ingredients. Biosimilar Active Ingredients 2026-08-10
South Africa Provision Of Npo Funding For Care And Support Services In All Districts For 36 Months 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Oxycodone And Naloxone (atc Code: N02aa55). 2026-08-11
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Medicines With The Active Ingredient Aclidinium Bromide (atc Code: R03bb05). 2026-08-11
Germany Drug Discount Agreements From April 1, 2026 On Various Active Ingredients As Part Of An Open House Procedure 2026-08-11
Finland Diagnostic Devices And Accessories 2026-08-11
Germany Open House Medicinal Product Discount Contracts According To § 130a Para. 8c Sgb V For The Kv Region Berlin 2026-08-11
France Market Aimed At The Purchase Of Raw Materials For Pharmaceutical Use, The Development, Manufacturing, Associated Services, And The Importation Of Medicines On Behalf Of The Pharmaceutical Establishment (ep) Of The Ap-hp As Well As, Where Applicable, The P 2026-08-11
Spain Radiofármacos 2026-08-11
Whats app